Along with the continuously increasing investment in healthcare delivery system, Alpha Bioventure focuses on international cooperation and exchange in biomedical research, committed to better health outcomes and lower total costs. At Alpha Bioventure, you can contribute to solving the toughest healthcare challenges and have an extraordinary impact on people’s lives.
Intending to recruit experts in SAPA in each pharmaceutical segment, such as: CMC, small molecule drugs and macromolecular drugs chemistry, biology, toxicology, clinical, FDA / CFDA approval, genetic engineering, medical devices, diagnostics and more.
Each expert is not only involved in expert review, but also invests capital as AP.
★ Build up project and talent database;
★ Recruit projects in PA, NJ, NY through road show events;
★ Seek strategic partners with strong financial resources;
★ Business plan competition to booster community entrepreneurship.
Alpha Bioventure provides capital growth investments on a diversified basis, covering pharmaceuticals, healthcare equipment & services, food & drug discoveries, as well as biotech sectors. We are trying to make the best viable solutions for your healthcare projects. Join us!
iVIEW Therapeutics (iVIEW) is a clinical stage specialty pharmaceutical company focused on the research and development of innovative ophthalmic therapeutics. Out of the many assets in its current pipeline, the lead compound iVIEW-1201 for the treatment of viral conjunctivitis has entered global phase II clinical trials in early 2019.
Email: